National Notifiable Diseases Surveillance System, 1 July to 30 September 2013

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period 1 July to 30 September 2013.

Page last updated: 26 May 2014

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 64,122 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 July and 30 September 2013 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC). NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
All jurisdictions
Hepatitis B (newly acquired)
All jurisdictions
Hepatitis B (unspecified)
All jurisdictions
Hepatitis C (newly acquired)
All jurisdictions except Queensland
Hepatitis C (unspecified)
All jurisdictions
Hepatitis D
All jurisdictions
Gastrointestinal diseases
Botulism
All jurisdictions
Campylobacteriosis
All jurisdictions except New South Wales
Cryptosporidiosis
All jurisdictions
Haemolytic uraemic syndrome
All jurisdictions
Hepatitis A
All jurisdictions
Hepatitis E
All jurisdictions
Listeriosis
All jurisdictions
STEC, VTEC*
All jurisdictions
Salmonellosis
All jurisdictions
Shigellosis
All jurisdictions
Typhoid
All jurisdictions
Quarantinable diseases
Cholera
All jurisdictions
Highly pathogenic avian influenza in humans
All jurisdictions
Plague
All jurisdictions
Rabies
All jurisdictions
Severe acute respiratory syndrome
All jurisdictions
Smallpox
All jurisdictions
Viral haemorrhagic fever
All jurisdictions
Yellow fever
All jurisdictions
Sexually transmissible infections
Chlamydial infection
All jurisdictions
Donovanosis
All jurisdictions
Gonococcal infection
All jurisdictions
Syphilis - congenital
All jurisdictions
Syphilis <2 years duration
All jurisdictions
Syphilis >2 years or unspecified duration
All jurisdictions
Vaccine preventable diseases
Diphtheria
All jurisdictions
Haemophilus influenzae type b
All jurisdictions
Influenza (laboratory confirmed)
All jurisdictions
Measles
All jurisdictions
Mumps
All jurisdictions
Pertussis
All jurisdictions
Pneumococcal disease (invasive)
All jurisdictions
Poliomyelitis
All jurisdictions
Rubella
All jurisdictions
Rubella - congenital
All jurisdictions
Tetanus
All jurisdictions
Varicella zoster (chickenpox)
All jurisdictions except New South Wales
Varicella zoster (shingles)
All jurisdictions except New South Wales
Varicella zoster (unspecified)
All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC)
All jurisdictions
Barmah Forest virus infection
All jurisdictions
Dengue virus infection
All jurisdictions
Japanese encephalitis virus infection
All jurisdictions
Kunjin virus infection
All jurisdictions
Malaria
All jurisdictions
Murray Valley encephalitis virus infection
All jurisdictions
Ross River virus infection
All jurisdictions
Zoonoses
Anthrax
All jurisdictions
Australian bat lyssavirus
All jurisdictions
Brucellosis
All jurisdictions
Leptospirosis
All jurisdictions
Lyssavirus (NEC)
All jurisdictions
Ornithosis
All jurisdictions
Q fever
All jurisdictions
Tularaemia
All jurisdictions
Other bacterial infections
Legionellosis
All jurisdictions
Leprosy
All jurisdictions
Meningococcal infection
All jurisdictions
Tuberculosis
All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 July to 30 September 2013, by date of diagnosis*
  State or territory Total 3rd quarter 2013 Total 2nd quarter 2012 Total 3rd quarter 2012 Last 5 years mean 3rd quarter Ratio Year to date 2013 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitisB (unspecified), hepatitis C (unspecified), leprosy, syphilis and tuberculosis, the earliest of specimen date, health professional notification date or public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only cervical, urine and urethral specimens; the Northern Territory and Western Australia exclude ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)
2
5
1
8
1
1
6
10
34
44
55
60.0
0.6
124
173.0
Hepatitis B (unspecified)
33
707
65
243
87
12
448
292
1,887
1,773
1,755
1,760.0
1.1
5,287
5,103.4
Hepatitis C (newly acquired)
1
16
0
NN
14
5
28
32
96
74
112
97.4
1.0
285
306.2
Hepatitis C (unspecified)
53
940
61
626
116
66
583
331
2,776
2,518
2,492
2,705.6
1.0
7,726
7,962.4
Hepatitis D
0
2
0
1
0
0
5
0
8
17
5
8.6
0.9
40
28.6
Gastrointestinal diseases
Botulism
0
1
0
0
0
0
0
0
1
1
0
0.2
5.0
4
0.6
Campylobacteriosis
90
NN
44
860
506
124
1,391
509
3,524
3,221
3,681
3,871.4
0.9
10,207
12,001.2
Cryptosporidiosis
1
74
12
94
20
4
170
45
420
1,138
334
289.4
1.5
3,276
2,219.2
Haemolytic uraemic syndrome
0
1
0
1
0
0
0
0
2
2
3
3.2
0.6
8
12.4
Hepatitis A
3
12
0
13
0
0
14
3
45
42
39
55.2
0.8
156
198.0
Hepatitis E
0
0
0
0
0
0
1
1
2
6
4
7.4
0.3
23
31.4
Listeriosis
0
7
0
0
1
1
5
1
15
17
18
15.0
1.0
61
59.4
STEC, VTEC§
0
0
0
64
10
1
2
1
78
28
19
19.2
4.1
149
69.8
Salmonellosis
47
534
94
479
226
34
566
275
2,255
3,046
2,026
1,789.4
1.3
9,443
8,013.0
Shigellosis
1
40
22
15
9
0
27
15
129
116
105
130.2
1.0
387
462.6
Typhoid
1
6
0
2
1
0
2
4
16
29
17
20.4
0.8
112
87.6
Quarantinable diseases
Cholera
0
0
0
0
0
0
0
0
0
1
1
1.2
0.0
1
3.8
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
1.0
Sexually transmissible infections
Chlamydial infection||,
304
5,079
808
4,932
1,312
344
4,663
2,977
20,419
20,794
20,192
17,760.4
1.1
62,192
54,535.6
Donovanosis
0
0
0
0
0
0
0
0
0
0
1
0.4
0.0
0
1.0
Gonococcal infection
24
1,069
464
685
213
15
709
447
3,626
3,858
3,196
2,430.6
1.5
11,318
7,804.6
Syphilis – congenital
0
1
0
0
0
0
0
2
3
2
0
1.0
3.0
6
3.0
Syphilis < 2 years duration
3
144
10
80
10
3
192
18
460
408
404
330.2
1.4
1,316
1,016.4
Syphilis > 2 years or unspecified duration‡,
3
108
14
76
37
4
140
87
469
462
328
348.4
1.3
1,322
1,020.4
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
1
0.8
Haemophilus influenzae type b
0
3
0
2
0
0
3
0
8
5
5
4.2
1.9
16
15.4
Influenza (laboratory confirmed)
388
6,288
114
2,589
2,381
162
3,777
1,295
16,994
2,522
32,898
21,526.0
0.8
21,842
28,208.8
Measles
0
8
0
15
0
0
19
1
43
17
129
41.2
1.0
70
106.4
Mumps
0
12
1
13
2
1
9
5
43
63
52
39.8
1.1
178
145.0
Pertussis
60
560
24
901
224
63
705
442
2,979
2,554
5,480
6,881.4
0.4
9,137
19,309.8
Pneumococcal disease (invasive)
1
173
20
93
34
13
146
73
553
447
730
668.0
0.8
1,208
1,343.2
Poliomyelitis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
0
7
0
2
0
0
1
1
11
7
9
11.2
1.0
19
34.2
Rubella – congenital
0
0
0
0
0
0
0
0
0
1
1
0.2
0.0
1
0.2
Tetanus
0
0
0
0
0
0
0
0
0
1
2
0.6
0.0
4
3.0
Varicella zoster (chickenpox)
2
NN
23
127
72
9
229
105
567
433
601
553.8
1.0
1,370
1,308.6
Varicella zoster (shingles)
12
NN
62
12
403
60
284
303
1,136
1,284
1,083
788.6
1.4
3,619
2,434.8
Varicella zoster (unspecified)
41
NN
2
1,483
35
25
829
302
2,717
2,240
2,035
1,720.0
1.6
7,189
5,004.6
Vectorborne diseases
Arbovirus infection (NEC)
0
0
0
8
0
0
0
0
8
4
2
3.2
2.5
17
9.0
Barmah Forest virus infection
2
76
79
461
20
1
13
147
799
1,559
284
284.6
2.8
3,784
1,297.6
Dengue virus infection
5
85
19
80
20
6
138
155
508
511
201
165.4
3.1
1,509
862.6
Japanese encephalitis virus infection
0
0
0
2
0
0
0
0
2
2
0
0.2
10.0
4
0.4
Kunjin virus infection**
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
1.2
Malaria
1
28
8
22
1
3
31
13
107
85
100
122.2
0.9
330
334.6
Murray Valley encephalitis virus infection**
0
0
0
1
0
0
0
0
1
0
0
0.0
0.0
1
4.4
Ross River virus infection
2
85
71
321
41
0
26
132
678
1,316
484
602.8
1.1
3,339
4,220.6
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Australian bat lyssavirus
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
1
0.0
Brucellosis
0
1
0
0
0
0
0
0
1
4
13
9.6
0.1
10
25.4
Leptospirosis
0
4
0
16
1
0
2
0
23
40
11
18.4
1.3
77
121.6
Lyssavirus (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
1
0
0
0
0
8
0
9
16
16
18.0
0.5
32
54.0
Q fever
0
31
0
67
3
0
12
2
115
141
89
82.0
1.4
356
258.8
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.5
Other bacterial infections
Legionellosis
0
33
1
80
10
0
14
33
171
113
99
73.8
2.3
381
237.6
Leprosy
1
0
0
0
0
0
1
1
3
4
2
2.0
1.5
9
6.0
Meningococcal infection††
1
20
1
5
6
2
10
4
49
27
83
87.2
0.6
115
193.4
Tuberculosis
5
113
12
29
19
5
105
44
332
290
335
342.2
1.0
943
936.6
Total
1,087
16,274
2,032
14,508
5,835
964
15,314
8,108
64,122
51,283
79,531
169,005

Top of page

Table 3: Notification rates of diseases, 1 July to 30 September 2013, by state or territory. (Annualised rate per 100,000 population)*,†
  State or territory  
Disease ACT NSW NT Qld SA Tas. Vic. WA Aust.
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis and tuberculosis, the earliest of specimen date, health professional notification date or public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only cervical, urine and urethral specimens; the Northern Territory and Western Australia exclude ocular infections.

** The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)
2.1
0.3
1.7
0.7
0.2
0.8
0.4
1.6
0.6
Hepatitis B (unspecified)§
35.2
38.7
110.6
21.3
21.0
9.4
31.8
48.0
33.2
Hepatitis C (newly acquired)
1.1
0.9
0.0
NN
3.4
3.9
2.0
5.3
2.1
Hepatitis C (unspecified)§
56.5
51.5
103.7
54.8
28.0
51.5
41.4
54.4
48.9
Hepatitis D
0.0
0.1
0.0
0.1
0.0
0.0
0.4
0.0
0.1
Gastrointestinal diseases
Botulism
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis
96.0
NN
74.8
75.3
122.2
96.8
98.8
83.7
91.5
Cryptosporidiosis
1.1
4.1
20.4
8.2
4.8
3.1
12.1
7.4
7.4
Haemolytic uraemic syndrome
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
Hepatitis A
3.2
0.7
0.0
1.1
0.0
0.0
1.0
0.5
0.8
Hepatitis E
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.0
Listeriosis
0.0
0.4
0.0
0.0
0.2
0.8
0.4
0.2
0.3
STEC, VTEC||
0.0
0.0
0.0
5.6
2.4
0.8
0.1
0.2
1.4
Salmonellosis
50.1
29.3
159.9
42.0
54.6
26.5
40.2
45.2
39.7
Shigellosis
1.1
2.2
37.4
1.3
2.2
0.0
1.9
2.5
2.3
Typhoid fever
1.1
0.3
0.0
0.2
0.2
0.0
0.1
0.7
0.3
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Human pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydial infection,**
324.3
278.3
1,374.3
432.1
316.9
268.6
331.3
489.5
359.6
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection**
25.6
58.6
789.2
60.0
51.4
11.7
50.4
73.5
63.9
Syphilis – congenital
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.3
0.1
Syphilis < 2 years duration**
3.2
7.9
17.0
7.0
2.4
2.3
13.6
3.0
8.1
Syphilis > 2 years or unspecified duration§,**
3.2
5.9
23.8
6.7
8.9
3.1
9.9
14.3
8.3
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.2
0.0
0.2
0.0
0.0
0.2
0.0
0.1
Influenza (laboratory confirmed)
414.0
344.5
193.9
226.8
575.0
126.5
268.4
212.9
299.3
Measles
0.0
0.4
0.0
1.3
0.0
0.0
1.4
0.2
0.8
Mumps
0.0
0.7
1.7
1.1
0.5
0.8
0.6
0.8
0.8
Pertussis
64.0
30.7
40.8
78.9
54.1
49.2
50.1
72.7
52.5
Pneumococcal disease (invasive)
1.1
9.5
34.0
8.1
8.2
10.1
10.4
12.0
9.7
Poliomyelitis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.4
0.0
0.2
0.0
0.0
0.1
0.2
0.2
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
2.1
NN
39.1
11.1
17.4
7.0
16.3
17.3
14.7
Varicella zoster (shingles)
12.8
NN
105.5
1.1
97.3
46.8
20.2
49.8
29.5
Varicella zoster (unspecified)
43.7
NN
3.4
129.9
8.5
19.5
58.9
49.7
70.5
Vectorborne diseases
Arbovirus infection (NEC)
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.0
0.1
Barmah Forest virus infection
2.1
4.2
134.4
40.4
4.8
0.8
0.9
24.2
14.1
Dengue virus infection
5.3
4.7
32.3
7.0
4.8
4.7
9.8
25.5
8.9
Japanese encephalitis virus infection
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection††
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
1.1
1.5
13.6
1.9
0.2
2.3
2.2
2.1
1.9
Murray Valley encephalitis virus infection††
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
2.1
4.7
120.8
28.1
9.9
0.0
1.8
21.7
11.9
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Leptospirosis
0.0
0.2
0.0
1.4
0.2
0.0
0.1
0.0
0.4
Lyssavirus (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.1
0.0
0.0
0.0
0.0
0.6
0.0
0.2
Q fever
0.0
1.7
0.0
5.9
0.7
0.0
0.9
0.3
2.0
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
0.0
1.8
1.7
7.0
2.4
0.0
1.0
5.4
3.0
Leprosy
1.1
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.1
Meningococcal infection‡‡
1.1
1.1
1.7
0.4
1.4
1.6
0.7
0.7
0.9
Tuberculosis
5.3
6.2
20.4
2.5
4.6
3.9
7.5
7.2
5.8

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Intelligence